Thursday 26 March

Update on SPCs

When and where

Date and time

Start: Thursday 26 March 2020, 12:30 PM

End: Thursday 26 March 2020, 01:30 PM

Event Overview

This webinar presented by Duncan Curley will  provide an update on the recent caselaw on SPCs: the end of the Truvada (Gilead v Teva and others) saga; the CJEU decisions of 2019 reviewed; discussion of the latest references; some thoughts on the SPC manufacturing waiver and finally, some speculation about what the future holds for SPCs in the UK, having “taken back control”.


Fellows, Students


Dr Duncan Curley

Dr Duncan Curley

Dr Duncan Curley qualified as a solicitor in 1995. He subsequently became a partner in the intellectual property department of an international law firm and then founded a boutique IP legal practice that he ran for 15 years. Duncan joined Penningtons Manches Cooper as a partner in 2022. The firm acts for multinational and UK-based generic pharmaceutical companies on regulatory, patent and trademark issues, including freedom to operate, patent clearance and litigation. Duncan is the author of numerous published articles on IP and regulatory issues, including the chapter on patents and regulatory data exclusivity for medicinal products in the recently published second edition of the OUP textbook “Overlapping Intellectual Property Rights”.

The event has been added to your basket:

Update on SPCs

Proceed to basket

Shopping Basket

No products in the cart.

Are you a CIPA member?

Sign in to your account to register for the event

Forgotten password?

If you are not yet registered or a member of CIPA, please register here

Skip to content